Brief: Active Biotech Q3 Loss After Tax At SEK 11.2 Mln
Nov 4 (Reuters) - Active Biotech AB publ ACTI.ST :
* REG-ACTIVE BIOTECH INTERIM REPORT JANUARY - SEPTEMBER 2021
* JULY-SEPT OPERATING LOSS AT SEK 11.3 MILLION VERSUS LOSS
SEK
8.3 MILLION YEAR AGO
* JULY-SEPT LOSS AFTER TAX AT SEK 11.2 MILLION VERSUS LOSS
SEK 8.2
MILLION YEAR AGO
Source text for Eikon: ID:nGNX7vDnHL
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))